Health Catalyst (NASDAQ:HCAT) Upgraded at KeyCorp

KeyCorp upgraded shares of Health Catalyst (NASDAQ:HCAT) from a sector weight rating to an overweight rating in a report issued on Wednesday morning, MarketBeat Ratings reports. They currently have $9.00 price objective on the stock.

A number of other analysts have also recently weighed in on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $16.00 price target on shares of Health Catalyst in a research report on Friday, October 4th. Evercore ISI increased their target price on Health Catalyst from $8.00 to $10.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Royal Bank of Canada boosted their price target on shares of Health Catalyst from $8.00 to $9.00 and gave the company a “sector perform” rating in a report on Thursday, November 7th. Stephens increased their price objective on shares of Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a report on Thursday, November 14th. Finally, Piper Sandler reissued an “overweight” rating and set a $12.00 target price (up from $11.00) on shares of Health Catalyst in a research note on Tuesday, November 26th. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Health Catalyst presently has an average rating of “Moderate Buy” and a consensus target price of $11.45.

Health Catalyst Stock Performance

Health Catalyst stock opened at $6.89 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. Health Catalyst has a 12 month low of $5.42 and a 12 month high of $11.41. The company has a fifty day moving average price of $7.79 and a two-hundred day moving average price of $7.52. The company has a market cap of $419.24 million, a PE ratio of -5.10 and a beta of 1.36.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). The business had revenue of $76.40 million during the quarter, compared to analyst estimates of $76.27 million. Health Catalyst had a negative net margin of 26.20% and a negative return on equity of 7.51%. The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the firm posted ($0.22) earnings per share. Research analysts expect that Health Catalyst will post -0.33 earnings per share for the current year.

Insiders Place Their Bets

In other Health Catalyst news, COO Daniel Lesueur sold 5,209 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.51, for a total transaction of $39,119.59. Following the completion of the transaction, the chief operating officer now directly owns 91,253 shares of the company’s stock, valued at approximately $685,310.03. This trade represents a 5.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Linda Llewelyn sold 6,442 shares of the business’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $7.88, for a total value of $50,762.96. Following the completion of the sale, the insider now directly owns 98,702 shares in the company, valued at $777,771.76. This represents a 6.13 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 76,051 shares of company stock worth $612,614. 2.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Quest Partners LLC bought a new position in shares of Health Catalyst during the 3rd quarter valued at about $34,000. Quarry LP lifted its stake in Health Catalyst by 59.4% during the second quarter. Quarry LP now owns 7,002 shares of the company’s stock valued at $45,000 after purchasing an additional 2,610 shares during the last quarter. nVerses Capital LLC bought a new stake in Health Catalyst during the third quarter worth approximately $59,000. Mackenzie Financial Corp acquired a new position in Health Catalyst in the second quarter worth approximately $70,000. Finally, Quadrature Capital Ltd bought a new position in shares of Health Catalyst in the third quarter valued at $84,000. 85.00% of the stock is owned by institutional investors and hedge funds.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.